These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12227726)

  • 1. Arterial hypertension and left ventricular hypertrophy in hemodialysis patients.
    Paoletti E; Cannella G
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S46-51. PubMed ID: 12227726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
    Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
    Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodialysis-associated hypertension: pathophysiology and therapy.
    Hörl MP; Hörl WH
    Am J Kidney Dis; 2002 Feb; 39(2):227-44. PubMed ID: 11840363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
    Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients.
    Cannella G; Paoletti E; Ravera G; Cassottana P; Araghi P; Mulas D; Peloso G; Delfino R; Messa P
    Kidney Int; 2000 Jul; 58(1):260-8. PubMed ID: 10886571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
    Ruilope LM; Schmieder RE
    Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: a randomized clinical trial.
    Paoletti E; Cassottana P; Amidone M; Gherzi M; Rolla D; Cannella G
    Am J Kidney Dis; 2007 Jul; 50(1):133-42. PubMed ID: 17591533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Left ventricular hypertrophy in chronic kidney disease].
    Paoletti E; Cannella G
    G Ital Nefrol; 2006; 23(6):560-8. PubMed ID: 17173262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reply to Paoletti and Canella (Clin Nephrol 58: S46-S51).
    Shaldon S
    Clin Nephrol; 2002 Oct; 58(4):321. PubMed ID: 12400850
    [No Abstract]   [Full Text] [Related]  

  • 10. Is regression of left ventricular hypertrophy in maintenance hemodialysis patients possible?
    Bossola M; Tazza L; Vulpio C; Luciani G
    Semin Dial; 2008; 21(5):422-30. PubMed ID: 18764802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug therapy for hypertension in hemodialysis patients.
    Hörl MP; Hörl WH
    Semin Dial; 2004; 17(4):288-94. PubMed ID: 15250920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evidence for low-dose combinations in patients with left ventricular hypertrophy.
    Dahlöf B
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S9-14. PubMed ID: 16075032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between angiotensin converting enzyme gene, chymase gene and regression of left ventricular hypertrophy in patients treated with angiotensin converting enzyme inhibitors].
    He H; Li LM; Cao WH; Liu MZ; Sun NL; Lü J; Hu YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):756-60. PubMed ID: 15555355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between hypervolemia and ventricular hypertrophy in hemodialysis patients.
    Martin LC; Franco RJ; Gavras I; Matsubara BB; Garcia S; Caramori JT; Barretti BB; Balbi AL; Barsanti R; Padovani C; Gavras H
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1163-9. PubMed ID: 15607624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hypertension in a hemodialysis population.
    Mittal SK; Kowalski E; Trenkle J; McDonough B; Halinski D; Devlin K; Boylan E; Flaster E; Maesaka JK
    Clin Nephrol; 1999 Feb; 51(2):77-82. PubMed ID: 10069642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
    Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Left ventricular hypertrophy in patient on dialysis].
    Lovcić V; Sebetić D; Klobucić M; Kusec V
    Acta Med Croatica; 2003; 57(1):61-4. PubMed ID: 12876866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Left ventricular hypertrophy in end-stage renal disease and its possible regression as a result of correction of anemia and arterial hypertension].
    Dzgoeva FU; Gatagonova TM; Kadzaeva ZK; Khamitsaeva OV; Kochisova ZKh; Dzutseva AT; Bazaeva BG
    Ter Arkh; 2011; 83(6):42-6. PubMed ID: 21786575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ramipril on left ventricular mass in normotensive hemodialysis patients.
    Yu WC; Lin YP; Lin IF; Chuang SY; Chen CH
    Am J Kidney Dis; 2006 Mar; 47(3):478-84. PubMed ID: 16490627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.